Mycoplasma Respiratory Disease in Reptiles

What Mycoplasma Respiratory Disease Is

Reptile mycoplasma respiratory disease — most commonly referred to as upper respiratory tract disease (URTD) — is a chronic bacterial infection of the respiratory tract caused by various Mycoplasma species. The classic example, and the one most studied, is Mycoplasma agassizii in desert tortoises (Gopherus agassizii) and gopher tortoises (G. polyphemus). Species-variant infections are documented in many other reptiles, including box turtles (Mycoplasma sp.), Russian and other Mediterranean tortoises, freshwater turtles, bearded dragons, and snakes.

Mycoplasmas are unusual bacteria — they lack a cell wall, which makes them resistant to several common antibiotic classes (beta-lactams in particular). They are slow-growing, often chronic, and tend to produce carrier states in which the animal harbors the organism for life with intermittent clinical flares. This biology shapes both the diagnostic and the treatment approach.

The clinical implications are significant. Once an animal is infected, full clearance of the organism is uncommon. Treatment aims to reduce clinical signs and viral shedding, not to eradicate. A reptile that has recovered clinically can still transmit infection. Collections that have ever had a clinical case should assume the organism is present until proven otherwise.

Clinical Signs and Species Susceptibility

Clinical signs are remarkably consistent across affected species:

• Nasal discharge — serous (clear) early, mucopurulent (thick, cream-colored) as infection progresses. Discharge often crusts around the nares.
• Ocular discharge — watery eyes early, sometimes progressing to swollen eyelids and palpebral edema.
• Lethargy and reduced activity — animals bask less and move less.
• Anorexia — particularly in tortoises, where appetite drops alongside the discharge.
• Audible respiratory sounds — rasping, clicking, or whistling on inspiration.
• In snakes — open-mouth breathing, gaping, and stargazing-like postures in severe cases (note that stargazing also raises IBD differential — see snake inclusion body disease IBD virus overview).

Species at highest risk in the pet trade: desert tortoises and gopher tortoises (the original M. agassizii hosts), Russian tortoises in mixed-species collections, box turtles in over-humid setups, and bearded dragons in poorly ventilated enclosures. Snakes can develop respiratory mycoplasmosis but classical bacterial respiratory infections (often from Aeromonas or Pseudomonas) are more common — see corn snake respiratory infection for the differential framework in colubrid snakes.

Predisposing Factors and Stress

Mycoplasma carriage in reptile populations is often subclinical for long periods. Clinical disease typically emerges after a stressor compromises immune function:

• Inappropriate temperatures — chronic hypothermia is a major immunosuppressant in ectotherms. See reptile temperature gradient and thermoregulation deep dive.
• Inadequate UVB exposure leading to MBD and immune compromise — see metabolic bone disease MBD in reptiles comprehensive diagnosis and treatment.
• Transport stress — animals recently acquired or moved between collections.
• Mixing with conspecifics carrying different strain populations.
• Concurrent parasitic burden, especially in wild-caught or rescue-intake animals.
• Poor enclosure hygiene — accumulated ammonia damages respiratory epithelium.

This pattern matters for management. Improving husbandry parameters often produces clinical improvement before any antibiotic course completes — and stable husbandry is essential for keeping the infection in subclinical remission long-term.

Diagnostic Workup

An ARAV-certified or ABVP-Reptile/Amphibian-board-certified vet should evaluate any reptile with suspected respiratory disease. The diagnostic workup includes:

• Physical exam — auscultation, nasal and oral inspection, ocular exam, hydration assessment.
• PCR testing — the standard for mycoplasma diagnosis. Performed on choanal swabs (tortoises), nasal flush samples, or oral swabs. Multiple labs offer the test, often as part of a respiratory pathogen panel that also screens for herpesvirus, ranavirus, and adenovirus. PCR is the most sensitive antemortem test available.
• Radiographs — evaluate lower respiratory tract for pneumonia, foreign body, or other pathology that may mimic or complicate mycoplasma.
• Bloodwork — complete blood count and biochemistry to assess overall health and any concurrent disease.
• Culture and sensitivity — mycoplasmas are difficult to culture, but other respiratory bacteria (commonly co-infecting) can be cultured to guide adjunct antibiotic choice.

Find an exotics vet familiar with reptile respiratory disease — see finding a reptile veterinarian ARAV and ABVP reptile amphibian.

Treatment

Treatment combines husbandry optimization, antibiotic therapy, and supportive care.

Antibiotic choice is constrained by mycoplasma biology. Beta-lactams (penicillins, cephalosporins) are ineffective because mycoplasmas lack a cell wall. Effective options that target intracellular mycoplasmas include fluoroquinolones (enrofloxacin) and tetracyclines (doxycycline). Both are used extra-label in reptiles — there are no FDA-approved reptile-specific products. Dosing is species-specific and pharmacokinetics vary substantially between, for example, desert tortoises and bearded dragons. Do not extrapolate antibiotic doses from dog/cat references, human references, or online forums — consult an ARAV-certified herp vet for current dosing.

Treatment courses are long — typically 4-12 weeks or longer. Mycoplasmas hide intracellularly, replicate slowly, and require sustained drug exposure for clinical resolution. Treatment-failure cases often turn out to be short-course or interrupted-course administration. Owners need to complete the full course even after symptoms resolve.

Supportive care includes fluid therapy for dehydrated animals, nutritional support for anorectic animals, nebulization with saline (and sometimes drugs) to clear airway secretions, and warm soaks to support hydration. Maintain ideal temperature gradient throughout treatment — hypothermic animals do not clear infections well.

For toxicology-adjacent emergencies that may overlap with respiratory presentations, keep both the ASPCA Animal Poison Control Center (888-426-4435) and the Pet Poison Helpline (855-764-7661) numbers accessible. Both charge consultation fees but provide expertise in reptile pharmaceutical interactions.

Clinical Progression and Disease Course

Mycoplasma respiratory disease in reptiles rarely presents as a sudden severe infection. The typical course is a slow, stepwise progression that owners notice late because the early signs are easy to dismiss as a transient stress response.

The first sign in tortoises is usually a clear, watery discharge at the nares, sometimes seen only as a slight wet sheen during a basking session. Over days to weeks, the discharge thickens to a cream-colored mucopurulent character that often crusts around the nostrils. Eye involvement follows in many cases — initially a watery margin and slight conjunctival redness, progressing to swollen eyelids and chronic palpebral edema. Audible respiratory sounds (clicking, whistling, light wheezing on inspiration) typically appear once the lower respiratory tract is involved. Anorexia and lethargy are late-stage signs, often the first clue that finally drives owners to the vet weeks or months after the discharge started.

In bearded dragons and snakes, the early signs are subtler. A reptile that “just isn’t basking like usual” or “is hiding more” can be in the early stages of respiratory mycoplasmosis. Open-mouth breathing, audible exhalation, or visible discharge from the nares or mouth indicates established disease. Snakes may adopt a head-elevated posture, sometimes confused with the stargazing of inclusion body disease — the differential matters and PCR testing distinguishes them.

Disease course untreated tends toward chronicity rather than acute decline. Many affected animals live for months to years with low-grade respiratory disease that periodically flares with stress. Owners often misread the intermittent flare pattern as separate “colds.” It is the same infection cycling with the animal’s immune state.

Diagnostic Workup in Detail

A working diagnostic workup for a reptile with suspected respiratory mycoplasmosis combines physical exam, sample collection, imaging, and bloodwork. The order and depth depend on the species and the severity of presentation.

Sample collection for PCR. The standard test for mycoplasma is PCR on a swab of the upper respiratory mucosa. In tortoises, a choanal swab — a small swab inserted gently into the back of the oral cavity to sample the choanal slit — is the highest-yield sample type. Nasal flush samples (sterile saline gently instilled into the nares and collected as it returns) are an alternative when choanal access is difficult. Several US labs run mycoplasma PCR panels (often bundled with herpesvirus, ranavirus, and adenovirus screens), with turnaround times of 1-2 weeks.

Serology. ELISA-based serology tests for anti-Mycoplasma agassizii antibodies are available for desert and gopher tortoise populations and are used in field surveys and research. Serology indicates prior exposure rather than active infection, so it is most useful in combination with PCR — a PCR-positive, antibody-positive animal is an active case; a PCR-negative, antibody-positive animal is a prior-exposure carrier in remission.

Radiographs. Plain-film radiographs evaluate the lower respiratory tract for pneumonia, consolidation, or pulmonary granulomas. Many cases of suspected URTD turn out to have concurrent lower-respiratory involvement detectable only on imaging. Three-view radiographs (dorsoventral, lateral horizontal-beam, craniocaudal) are standard for chelonians.

Bloodwork. A complete blood count and biochemistry panel evaluates overall health, hydration status, organ function, and any concurrent illness. Chronically infected animals often show mild anemia, heterophilia with toxic changes, and elevated globulin reflecting chronic immune activation.

Wild-Population Context and Conservation

Reptile mycoplasma respiratory disease has significance beyond the home keeper. The original work characterizing Mycoplasma agassizii in the late 1980s and 1990s was driven by mass die-offs in wild desert tortoise populations across the Mojave and Sonoran deserts. Genetic analyses suggest the introduction of the organism into wild populations was at least partly attributable to released captive tortoises — animals taken into homes as pets, then released back into the wild when owners could no longer care for them.

The wild desert tortoise (Gopherus agassizii) is now federally listed as threatened in the United States, with multiple recovery units across its range. URTD remains one of the documented contributors to ongoing population declines, alongside habitat fragmentation, raven predation on hatchlings, and prolonged drought. Gopher tortoises (G. polyphemus) face a similar pattern in the southeastern US, where they hold keystone-species status for their burrows that shelter dozens of other species.

The practical implications for pet keepers reach beyond personal collection biosecurity. Never release a captive tortoise of any species into the wild — even an apparently healthy animal can introduce mycoplasma, herpesvirus, or ranavirus into a population with no immunity. State and federal wildlife agencies maintain rehoming networks for unwanted captive tortoises; the exotic pet rescue resources overview covers the contacts. The same principle applies to released box turtles, freshwater turtles, and any reptile that could mix with wild conspecifics.

Biosecurity and Carrier State

The carrier state is the central management challenge. An animal that clinically recovers may continue to shed mycoplasma intermittently for years. PCR-negative results after treatment are reassuring but not definitive — single negatives can occur in a carrier whose viral load is below detection threshold at the moment of sampling.

For multi-reptile collections, the implications are:

• Quarantine all new acquisitions for a minimum of 6 months with respiratory PCR screening during quarantine.
• Separate any animal with respiratory signs into immediate isolation.
• Treat known mycoplasma-positive animals as life-long carriers — never co-house with naïve animals.
• Disinfect tools and hands between enclosures. Mycoplasmas are sensitive to common disinfectants (chlorhexidine, F10 SC, dilute bleach) but require sustained contact time.
• Avoid mixing species in single enclosures — Russian tortoises housed with Mediterranean species or with desert tortoises have well-documented mycoplasma outbreak histories.

The exotic pet trade CB vs WC and source verification ethics guide covers acquisition-side risk reduction. Wild-caught animals carry substantially higher mycoplasma prevalence than well-sourced captive-bred animals.

Prevention

Prevention focuses on reducing introduction risk and maintaining the husbandry parameters that keep subclinical carriers from progressing to clinical disease:

• Source captive-bred animals from reputable breeders. Avoid swap-meet animals of unknown history.
• Quarantine all new acquisitions for 6 months minimum.
• Maintain species-appropriate temperature gradients — see reptile husbandry basics UVB heat humidity.
• Maintain species-appropriate humidity — see reptile humidity management and hygrometer calibration.
• Spot-clean droppings daily; full substrate replacement on schedule.
• Ensure adequate ventilation — stagnant enclosure air with elevated ammonia damages respiratory epithelium.
• Avoid co-housing species, especially across geographic origins.

Frequently Asked Questions

What causes upper respiratory tract disease in tortoises?

Mycoplasma agassizii is the most-studied causative agent, particularly in desert and gopher tortoises. Species-variant mycoplasmas affect other reptiles. Stress, hypothermia, and poor husbandry trigger clinical disease in subclinical carriers.

How is reptile mycoplasma diagnosed?

PCR testing on nasal or choanal swabs is the standard. Radiographs and bloodwork support the assessment; culture is difficult because mycoplasmas grow slowly and have specialized requirements.

Can mycoplasma in reptiles be cured?

Clinical signs can usually be resolved, but full eradication of the organism is uncommon. Most animals become lifelong carriers with intermittent shedding. Treatment aims to suppress active infection and minimize transmission, not to eliminate the organism.

What antibiotics treat reptile mycoplasma?

Enrofloxacin and doxycycline are commonly used extra-label. Beta-lactam antibiotics are ineffective because mycoplasmas lack a cell wall. Dosing is species-specific — consult an ARAV-certified herp vet rather than extrapolating from other species.

Can I introduce a new tortoise to my collection without testing?

Not safely. Quarantine for at least 6 months with respiratory PCR screening during quarantine. Wild-caught and swap-meet animals carry substantially higher mycoplasma risk than captive-bred animals from reputable breeders.